Supporting this finding, Peng et al. [64] demonstrated that PTEN loss in melanoma cell lines and clinical samples was correlated with increased expression of vascular endothelial growth factor (VEGF) cytokines, which recruit regulatory T cells (Tregs) and other suppressive immune cells to render the TME less permeable to CD8+ effector T cells. The gene discussed is VEGFA; the disease is melanoma.